What is the best medication for constipation?

Best Medication for Constipation

Polyethylene glycol (PEG) 17g daily is the best first-line medication for chronic constipation, with moderate-quality evidence showing superior efficacy in increasing bowel movements, achieving responder rates, and providing global symptom relief compared to placebo, while being widely available, inexpensive, and safe for long-term use up to 6 months. 1

Treatment Algorithm

First-Line: Osmotic Laxatives

Start with PEG 17g daily as your initial pharmacological intervention 1. The evidence supporting PEG is compelling:

• Increases complete spontaneous bowel movements (CSBMs) by 2.90 per week
• Increases spontaneous bowel movements (SBMs) by 2.30 per week
• Achieves responder rates 3.13 times higher than placebo (312 more per 1,000 patients)
• Provides global symptom relief in 454 more per 1,000 patients
• Demonstrated durable efficacy over 6 months in chronic idiopathic constipation 1

Practical considerations for PEG:

• Cost: $10-$45 per month 1
• Available over-the-counter without prescription
• Dose can be titrated based on response and tolerability
• Common side effects: bloating, flatulence, mild-to-moderate diarrhea (expected with any laxative)
• No serious safety concerns identified 1

Alternative osmotic laxative: Magnesium oxide 400-500mg daily (studies used 1,000-1,500mg daily) 1

• Cost: <$50 per month
• Critical caveat: Avoid in renal insufficiency due to hypermagnesemia risk 1
• Very low certainty of evidence compared to PEG 1

Second-Line: Secretagogues (If PEG Fails)

If osmotic laxatives prove inadequate after appropriate trial, escalate to intestinal secretagogues 1, 2:

Linaclotide 72-145μg daily (max 290μg daily)

• Cost: $523/month 1
• Additional benefit for abdominal pain 1
• Diarrhea may cause discontinuation in subset of patients

Lubiprostone 24μg twice daily

• Cost: $374/month 1
• May benefit abdominal pain 1
• Also approved for IBS-C at lower dose (8μg BID)

Plecanatide 3mg daily

• Cost: $526/month 1
• Similar profile to linaclotide

Third-Line: Prokinetics

Prucalopride 1-2mg daily (max 2mg daily)

• Cost: $563/month 1
• 5-HT4 agonist mechanism
• May provide additional abdominal pain benefit
• Side effects: headaches, diarrhea in subset of patients 1

Rescue/Short-Term Use Only: Stimulant Laxatives

Bisacodyl 5mg daily (max 10mg) or Senna 8.6-17.2mg daily 1

• Cost: <$50/month
• Use only for short-term or rescue therapy 1
• Long-term safety and efficacy unknown
• Side effects: cramping, abdominal discomfort, potential electrolyte imbalance with prolonged use 1

Key Clinical Pitfalls

1. Don't skip PEG: Despite FDA approval only for "occasional constipation," PEG has proven efficacy in chronic idiopathic constipation for up to 6 months 1. Its cost-effectiveness and safety profile make it the rational first choice.

2. Avoid magnesium in renal disease: Always check renal function before prescribing magnesium oxide 1

3. Reserve stimulant laxatives for rescue: These are not appropriate for chronic daily management due to unknown long-term safety 1

4. Consider defecatory disorders: If patients fail multiple laxatives, consider physiological testing for dyssynergic defecation, which requires biofeedback therapy rather than more medications 3

Evidence Quality Context

The 2023 AGA-ACG guideline 1 represents the highest-quality, most recent evidence available. PEG has moderate certainty evidence across multiple outcomes (CSBMs, SBMs, responder rates, global relief), while magnesium oxide has only very low certainty evidence 1. The newer secretagogues and prokinetics have robust trial data but are appropriately positioned as second-line due to cost and the principle of starting with simpler, proven therapies first.

The algorithmic approach prioritizes PEG first, escalates to secretagogues if inadequate response, and reserves stimulant laxatives strictly for rescue use—this maximizes both clinical outcomes (morbidity reduction, quality of life improvement) and cost-effectiveness.